XYTOS is able to illuminate cancer cells before the cancer would be detectable by current diagnostic procedures such as the mammogram.

The diagnostic technique allows XYTOS to fight cancer at the earliest stages, before a lump can develop.

XYTOS Fluorescent Scanning has the ability to detect cancer at its earliest stages well before it becomes a tumor as it is near the surface of the body.

XYTOS chairman and CEO Tim Cook said they are excited about the new non-invasive cancer diagnostic technique for detecting surface and near surface cancerous tumors.

"After taking XyChloro sublingually, XyChloro will fluoresce at a specific wavelength as the body is scanned with a laser," Cook said.

"Fluorescent radiation from XyChloro activated inside the tumors is detected with a camera fitted with a filter and displayed on a TV screen or computer."